AstraZeneca Will Pay Up to $6.9 Billion for Rights to Japanese Drugmaker’s Cancer Drug

AstraZeneca is aiming to expand its presence in the oncology industry with a new drug rights acquisition. The pharmaceutical company said on Thursday that it’s agreed to pay up to $6.9 billion for a cancer drug developed by Japanese drugmaker Daiichi-Sankyo. The sum includes an upfront payment of $1.4 billion and the possibility of paying […]

Xeralto to Become First Prescription Drug With TV Ads That Includes Pricing

Xeralto has been a popular drug-thinner for years–and the target of more than 25,000 lawsuits recently settled by Bayer AG and Johnson & Johnson for $775 million. Now Xeralto, a brand name for generic rivaroxaban, is getting some attention for something different. It’s about to become the first drug to include prices in television ads, […]

Fewer People Are Strategizing With Prescription Drug Choices to Control Their Health Care Costs

The U.S. has the highest drug prices in the world. Despite enormous expenses in research and marketing, pharmaceutical companies have the tenth highest profit levels among all industries. Despite some attention from Congress and the administration, prices remain high and promise to continue do so, at least in the immediate future. You might expect that […]

UnitedHealth Expands Drug Rebate Program to Consumers

UnitedHealth, the country’s largest health insurer, said Tuesday it would expand a program that passes drug manufacturer rebates directly to consumers, the Associated Press reported. Starting in 2020, new employer-sponsored health insurance coverage that used UnitedHealthcare and pharmacy benefit manager OptumRx, also a division of UnitedHealth, would have to include point-of-sale pharmacy discounts. The trial […]

U.S. Drug Prices, But Not Out-of-Pocket Costs, Are the World’s Highest

With drug prices rising sitting at 10% of skyrocketing health care costs and pharmaceutical companies socking away big profits, you might assume that the U.S. has the highest prescription drug spending in the world. And you’d be right. Per capita prescription expenses in 2016 were $1,016 in this country, while the comparable country average was […]

Drugmaker Lilly to Launch a Half-Price, Generic Version of Its Top-Selling Insulin

Drugmaker Eli Lilly & Co. will offer a half-priced version of its blockbuster insulin, becoming one of the first companies to effectively cut the price of a top-selling drug amid the ongoing U.S. debate over pharmaceutical costs. While it will continue selling its brand-name version at the existing price, Indianapolis-based Lilly will also sell a […]